Francesca Barone

2021

In 2021, Francesca Barone earned a total compensation of $364.8K as Chief Scientific Officer at Candel Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$101,500
Salary$259,728
Other$3,569
Total$364,797

Barone received $259.7K in salary, accounting for 71% of the total pay in 2021.

Barone also received $101.5K in non-equity incentive plan and $3.6K in other compensation.

Rankings

In 2021, Francesca Barone's compensation ranked 11,314th out of 12,406 executives tracked by ExecPay. In other words, Barone earned more than 8.8% of executives.

ClassificationRankingPercentile
All
11,314
out of 12,406
9th
Division
Manufacturing
4,993
out of 5,492
9th
Major group
Chemicals And Allied Products
2,212
out of 2,368
7th
Industry group
Drugs
1,966
out of 2,089
6th
Industry
Biological Products, Except Diagnostic Substances
430
out of 452
5th
Source: SEC filing on May 23, 2023.

Barone's colleagues

We found three more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2021.

2021

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

2021

Estuardo inf

Candel Therapeutics

Chief Executive Officer

2021

John Canepa

Candel Therapeutics

Chief Financial Officer

News

You may also like